251 related articles for article (PubMed ID: 22880087)
1. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated embryonic cell transcription factor-1 (UTF1) inhibits the growth of cervical cancer cells by transactivating p27Kip1.
Wu XL; Zheng PS
Carcinogenesis; 2013 Jul; 34(7):1660-8. PubMed ID: 23536577
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of undifferentiated cell transcription factor 1 in normal and cancerous human epithelia.
Mouallif M; Albert A; Zeddou M; Ennaji MM; Delvenne P; Guenin S
Int J Exp Pathol; 2014 Aug; 95(4):251-9. PubMed ID: 24738751
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Yang WT; Zheng PS
PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
[TBL] [Abstract][Full Text] [Related]
6. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
7. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.
Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK
Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
[TBL] [Abstract][Full Text] [Related]
10. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
Sova P; Feng Q; Geiss G; Wood T; Strauss R; Rudolf V; Lieber A; Kiviat N
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):114-23. PubMed ID: 16434596
[TBL] [Abstract][Full Text] [Related]
13. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
15. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
Sung HY; Ju W; Ahn JH
Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between RAR-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract][Full Text] [Related]
19. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
20. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
